Middle East & Africa Fluorescent Immunoassay Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis – by Product Type (ELISA, Rapid Lateral Flow Immunoassay, and Others), Application (Infectious Diseases, Oncology, Cardiovascular Diseases, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others) 

No. of Pages: 157
Report Code: BMIRE00025663
Category: Life Sciences
Middle East & Africa Fluorescent Immunoassay Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East & Africa Fluorescent Immunoassay Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East & Africa Fluorescent Immunoassay Market Regional Analysis

6.2 Middle East & Africa Fluorescent Immunoassay Market Revenue 2019-2028 (US$ Million)
6.3 Middle East & Africa Fluorescent Immunoassay Market Forecast Analysis

7. Middle East & Africa Fluorescent Immunoassay Market Analysis – by Product Type

7.1 ELISA
  • 7.1.1 Overview
  • 7.1.2 ELISA: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Rapid Lateral Flow Immunoassay
  • 7.2.1 Overview
  • 7.2.2 Rapid Lateral Flow Immunoassay: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Middle East & Africa Fluorescent Immunoassay Market Analysis – by Application

8.1 Infectious Diseases
  • 8.1.1 Overview
  • 8.1.2 Infectious Diseases: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Oncology
  • 8.2.1 Overview
  • 8.2.2 Oncology: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Cardiovascular Diseases
  • 8.3.1 Overview
  • 8.3.2 Cardiovascular Diseases: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Middle East & Africa Fluorescent Immunoassay Market Analysis – by End User

9.1 Hospitals & Clinics
  • 9.1.1 Overview
  • 9.1.2 Hospitals & Clinics: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Diagnostic Centers
  • 9.2.1 Overview
  • 9.2.2 Diagnostic Centers: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical & Biotechnology Companies
  • 9.3.1 Overview
  • 9.3.2 Pharmaceutical & Biotechnology Companies: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Academic & Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Academic & Research Institutes: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Middle East & Africa Fluorescent Immunoassay Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa
  • 10.2.1 Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 South Africa: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 South Africa: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.1.2 South Africa: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.1.3 South Africa: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.2 Saudi Arabia: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Saudi Arabia: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.2.2 Saudi Arabia: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.2.3 Saudi Arabia: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.3 UAE: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 UAE: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.3.2 UAE: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.3.3 UAE: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Fluorescent Immunoassay Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Danaher
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Ortho Clinical Diagnostics Holdings plc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Quidel Corporation
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Siemens AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sysmex Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Middle East & Africa Fluorescent Immunoassay Market

  • Abbott
  • BD
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Ortho Clinical Diagnostics Holdings plc
  • Quidel Corporation
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)